Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab deruxtecan)
Catalog No.
F1402
Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab deruxtecan)
Featured Products
Trastuzumab deruxtecan (T-DXd; DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-active molecule conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide linker, and a topoisomerase I inhibitor (toxin component Dxd). Trastuzumab deruxtecan can be used in the study of HER2-positive breast cancer and gastric cancer.
153.75 kDa
Dry ice
1826843-81-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ENHERTU, DS-8201a, DS8201a
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P04626
Human
Dxd
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ERBB2 / HER2 / CD340
Please avoid freeze-thaw cycles.